A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(5 sites)

United States

Praxis Research Site, La Jolla, California

Praxis Research Site, Gulf Breeze, Florida

Praxis Research Site, Chevy Chase, Maryland

Praxis Research Site, Roseville, Minnesota

Brazil

Praxis Research Site, São Paulo